SpringWorks Therapeutics Inc (SWTX US)

Analysis

Health Care • United States

SpringWorks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company acquires, develops, and commercializes medicines for patients suffering various diseases and cancer. SpringWorks Therapeutics serves customers in the United States.

No news found

We’ll display news we find for SpringWorks Therapeutics Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00